您的位置:首页 > 会议日程
Jia-Horng Kao
分享到:
National Taiwan University Hospital

Professor Jia-Horng Kao is the Chair Professor at the Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine. He is also the sitting President of Advancing Clinical Treatment-Liver Disease (ACT-LD), and an Attending Physician at the Department of Internal Medicine and Vice Superintendent of the National Taiwan University Hospital. Professor Kao graduated from the College of Medicine National Taiwan University in 1987 and received his Ph.D. from the Graduate Institute of Clinical Medicine at the same university in 1994. Professor Kao has been involved in viral hepatitis research for over 2 decades. He was the President of Taiwan Association for the Study of the Liver (TASL) from 2017 to 2019 and the Asian Pacific Association for the Study of the Liver in 2012, Director of the Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine from 2009 to 2015, Director of the Hepatitis Research Center at the National Taiwan University Hospital from 2003 to 2009, Secretary General of the Taiwan Association for the Study of the Liver between 2004 and 2005, and Vice Secretary General of the Gastroenterological Society of Taiwan from 2003 to 2006. 


Professor Kao’s main research interests include the prevention, natural history, molecular virology, pathogenesis and treatment of chronic viral hepatitis and HCC. He has published more than 600 articles with the sum of times cited of 22,835 and h-index of 69 by Web of Science. He also contributed to 9 book chapters and 2 monographs. With his outstanding academic achievements, he has received several prestigious awards including the Outstanding Research Award from the National Science Council, Taiwan for 3 times (1997, 2000, 2003); Outstanding Research Award for Excellence in Medical Research, National Taiwan University Hospital (2005); Y. Z. Hsu Outstanding Professor Award (2009); Academic Award, Ministry of Education, Executive Yuan (2011); Distinguished Scientific Award, Executive Yuan (2011); Okuda Award, Asian-Pacific Digestive Week (2012); Outstanding Academic Research Award of Mr. Lee TD’s Medical Foundation (2012); Outstanding Research Award of Distinguished Research Fellow, Ministry of Science and Technology (2014), National Chair Professorship, Ministry of Education (2015), AASLD Fellow (2015), NTU Chair Professorship (2016), Outstanding Research Team Award of the National Taiwan University Hospital (2017), Achievement Award of the Liver Disease Prevention and Treatment Research Foundation (2017), Outstanding Research Award of Wang Ming-Ning Foundation (2018), APASL Okuda-Omata Distinguished Achievement Award (2019), Outstanding Scholar Awards of Foundation for the  Advancement of Outstanding Scholarship (2020) , TECO Award (2020), APASL Chainuvati Lecture (2021), and World's Top 2% Scientists for career-long and single year impact (2020) by Stanford University. In 2021, ExpertScape named him top 0.01% world expert in Hepatitis over the past 10 years. 


Professor Kao is the Editor-in-Chief of the Journal of the Formosan Medical Association (JFMA), and sits on the editorial board of the Gastroenterology, GUT, Alimentary Pharmacology & Therapeutics (APT), Journal of Infectious Diseases (JID), as well as Clinical and Molecular Hepatology (CMH). He is a reviewer with 120 peer-reviewed journals, including the New England Journal of Medicine, Lancet, JAMA, Nature Communications, Annals of Internal Medicine, the Journal of the National Cancer Institute, Gastroenterology, Hepatology, Gut, Lancet Infectious Diseases, Nature Reviews Gastroenterology and Hepatology, Journal of Hepatology, American Journal of Gastroenterology, Clinical Infectious Diseases, Journal of Infectious Diseases, Emerging Infectious Diseases, Journal of Viral Hepatitis, Journal of Medical Virology and Kidney International. Professor Kao also serves as the Steering Council member of APASL, Council member of APAGE, the trustee of JGH foundation and the founding member of AASLD Asia Pacific Regional Advisory Council.



讲座视频:0

论文摘要:3

480

0

0

学术任务如下
日期 时间 会场 Session 角色 讲题
2022-11-18 09:30-11:00 Room 3

Symposium L1: Hepatitis B

主持
2022-11-18 13:50-14:10 Room 3

Symposium L2: Hepatitis C

讲者 Management of DAA failures in Asia